Abstract
INTRODUCTION
Colorectal cancer (CRC) is the most common gastro intestinal cancer, as well as the third leading cancer by incidence and mortality, in the United States [1] . The majority of CRC cases are sporadic, where a complex interaction among genetic and environmental factors impacts the carcinogenesis process. The underlying molecular changes follow at least two distinctive pathways of genomic dysfunction: the chromosomal instability (CIN) and CpG island methylator phenotype (CIMP)high pathways. CIN is observed in 70%85% of sporadic CRCs and describes aneuploidy due to gains or losses of whole or large portions of chromosomes [2, 3] . CIN is likely due to defects in chromosome segregation pathways and is likely initiated by the adenomatous polyposis coli (APC) mutation with subsequent βcatenin/ Wntsignaling pathway activation [4] . APC mutation is followed by a cascade of molecular changes in a multistep fashion, as the flat mucosa evolves into a progressively larger adenoma that ultimately turns into cancer (adenomacarcinoma sequence). CIMP high CRCs include microsatellite instability (MSI)high CRCs, with serrated polyps representing the main precursors [3] . These account for 15% of all CRCs and are characterized by inactivation of mismatch repair enzymes and other tumor suppressor genes via mutations or hypermethylation [58] . The human large intestine is a complex bacterial ecosystem that plays a significant role in health and disease. Increasing evidence suggests that a healthy symbiotic relationship between the host and microflora may be disrupted, leading to chronic metabolic and inflammatory changes promoting colorectal car cinogenesis [9, 10] . Although the technology to define the microbiome continues to evolve, the prevalence of some bacteria appears to be elevated in CRC. These include Fusobacteria, Alistipes, Porphyromonadaceae, Coriobacteriaceae, Staphylococcaceae, Akkermansia, and Methanobacteriales. Conversely, other bacteria exhibit reduced prevalence in CRC, including Bifidobacterium, Lactobacillus, Ruminococcus, Faecalibacterium spp., Roseburia, and Treponema [11] . Although more research is warranted to establish firm causative links between CRC and flora diversity, patterns, specific microbial populations, and microbial functions, we are particularly intrigued by current data regarding Fusobacterium, a genus of the strictly anaerobic Fusobacteria phylum. Oral Fusobacterium consists mainly of the species Fusobacterium nucleatum (F. nucleatum), an adherent [12] , invasive [13] , and proinflammatory [14, 15] bacterium that is linked to periodontal disease [16] . F. nucleatum is also the first anaerobic species to colonize the mouths of infants, indicating a potential prolonged exposure to F. nucleatum in adults who harbor it [1719] . F. nucleatum is classified into subspecies animalis, fusiforme, nucleatum, polymorphum, and vincentii [20] . F. varium is another Fusobacterium species and has been associated with ulcerative colitis [21, 22] . Other
Fusobacterium species, such as F. naviforme, are mainly oral commensals and are associated with periodontal health [19, 23] . The presence of Fusobacterium in the colon, specifically F. nucleatum, is increasingly linked to CRC through a variety of recent studies, albeit with significant heterogeneity in study methods and findings. Thus, a critical evaluation of the scientific literature regarding the link between Fusobacterium/F. nucleatum and CRC may contribute to the development of more comprehensive and novel studies to better define this relationship.
MATERIALS AND METHODS
Two independent reviewers (HH and KR) systematically queried PubMed, Embase, and Medline using the following search terms: ("Fusobacterium " {All fields} OR "Fusobacteria" {All fields}) AND ("colon" {All fields}), "rectum" {All fields}, "colorectal" {All fields}, "colorectal cancer" {All fields}, "polyps" {All fields}, "adenomas" {All fields}), "serrated" {All fields}, "SSA" {All fields}, "SSP" {All fields}, "CIMP" {All fields}, "MSI" {All fields}, OR "microsatellite" {All fields}). On the basis of this search, 355 articles were screened at the abstract level. The following inclusion criteria were used: (1) Original human, animal, and in vitro studies investigating Fusobacterium and colorectal neoplasia that were published between January 1, 2000, and July 1st, 2017; (2) articles written in English; and (3) studies relevant to colorectal neoplasia. We excluded: (1) abstracts; (2) review articles; and (3) studies investigating other colonic diseases, such as ulcerative colitis. Ninety original articles were included after removing duplicates, resolving disagreements between the two reviewers, and applying the above criteria. The resulting 90 articles were then independently reviewed at the manuscript level by HH and KR. We used the Hill criteria to assess causality in the current evidence linking F. nucleatum and CRC [24] . A brief illustration of our methods is shown in Figure 1 .
RESULTS

Associations with CRC
Associations between Fusobacterium and CRC: Consistent casecontrol studies using various samples including both stool and fresh and formalin-fixed paraffinembedded (FFPE) colonic tissue demonstrated increased detection, quantity, and/or relative percentage of Fusobacterium rDNA copies in CRC tissue compared with matched adjacent noncancerous tissue and compared with healthy controls without colorectal neoplasia, as 8628 December 28, 2017|Volume 23|Issue 48| WJG|www.wjgnet.com for future studies to utilize unprepared freshfrozen colonic samples (for instance, unprepped flexible sigmoidoscopy with biopsies) when possible, combined with wholegenome shotgun metagenomic sequencing, in order to potentially yield more accurate detection and quantification of Fusobacterium and F. nucleatum.
Relation between Fusobacterium and dietary characteristics of CRC patients: Lowfiber, high fat Western diet administration over 2 wk to 20 Native Africans was associated with altered colonic microbiome and increased number of F. nucleatum rDNA copies in colonic tissue, in association with increases in early colonic biomarkers of CRC [63] . It is interesting to note that colonic biopsies quantity of F. nucleatum rDNA copies did not decrease in 20 African Americans switched from a Western diet to a highfiber, lowfat diet for 2 wk. This could be due to the small sample size, or it could take longer than 2 wk for dietary changes to reverse F. nucleatum rDNA abundance in colonic tissue [63] . Recently, vegetable consumption was also inversely associated with relative concentration of Fusobacterium rDNA in stool of patients with advanced adenomas [54] . However, the same study did not find associations between relative concentration of Fusobacterium rDNA in stools of 46 CRC patients and dietary habits such as consumption of red meat, processed meat, any meat, vegetables, or whole grains. This finding may be due to the crosssectional nature of the study or to the researchers' superficial assessment of dietary habits and use of fecal samples as opposed to colonic tissue in their study [54] . Mehta et al [64] prospectively investigated longterm dietary patterns in a cohort of 137217 patients using validated food frequency questionnaires. There were 1019 incidences of CRCs, which were classified in into F. nucleatumpositive or F. nucleatumnegative CRCs based on presence or absence of F. nucleatum rDNA in CRC tissue respectively. They identified that, when compared with a Western diet, a diet rich in whole grains and dietary fiber (prudent diet) was associated with a lower risk of F. nucleatum positive CRCs, with a hazard ratio (HR) of 0.43 (95%CI: 0.250.72; P = 0.003). No associations between prudent diet and F. nucleatum-negative CRC risk was identified, indicating a differential impact of prudent diet on CRC risk that are F. nucleatum-positive specifically [64] . These inverse associations between prudent diet and F. nucleatumpositive CRCs were more pronounced when comparing high fiber intake (> 26 g/d for men and > 19 g/d for women) with the lowest fiber intake quartile (< 18 g/d for men and < 13 g/d for women; P = 0.04). Cereal-derived fiber had the strongest inverse association with F. nucleatumpositive CRCs (HR = 0.58; 95%CI: 0.340.99; P = 0.03) [64] . Fruit consumption was also shown to reduce the risk of both F. nucleatumpositive and F. nucleatum-negative CRCs, with no specific relation to F. nucleatum status of the CRC [64] . The researchers observed no impact of prudent diet subgroups (vege tables, legumes, or whole grains), on F. nucleatum positive CRC risk, as also previously demonstrated [29, 54, 64] . summarized in Table 1 [2540]
. The histopathology of these findings is ambiguous, but some data suggest that Fusobacteria have been observed within the colonic bacterial biofilms, in the colonic mucus layer, within colonic crypts, and invading the colonic epithelium [33, 4143] . F. nucleatum was the detected species of Fusobacterium in CRC tissue in 13 out of the 15 studies that presented specieslevel analysis [41, 4455] . In two out of three studies that presented subspecieslevel analysis, F. nucleatum subspecies animalis was the most frequent subspecies of F. nucleatum in CRC tissue [40, 54, 56] . Other Fusobacterium species, such as F. periodonticum, F. varium, F. ulcerans F. necrophorum, and F. gonidiaformans, were also identified in CRC tissue in the five remaining studies [51, 54, 5658] . F. nucleatum, F. periodonticum, F. varium, and F. ulcerans species can actively invade host cells, independently of mucosal compromise or presence of coinfection with other bacteria [59, 60] . Conversely, F. necrophorum and F. gonidiaformans are termed passive invaders, and their presence in CRC could be due to the disruption of the mucus layer seen with CRC or to coinfection with other invasive bacteria. In the largest study comparing genes of Fusobacterium species, active invaders such as F. nucleatum were found to harbor larger genomes encode adhesions, and contain twice as many genes encoding membranerelated proteins compared with other Fusobacterial species termed passive invaders [59] . Thus, the presence of multiple Fusobacterial species could be due to their virulence and/or to early changes in the colonic environment that facilitate their presence in CRC tissue. Further studies are warranted to answer this question.
No major associations were found between F. nucleatum and characteristics of CRC patients such as age, gender, ethnicity, body mass index (BMI), smoking, or alcohol consumption, except in one South African study, where researchers found an association between Fusobacterium and both African race and age less than 60 [29, 31, 42, 49, 50, 54, 61, 62] . In all studies, the prevalence of F. nucleatum rDNA in CRC tissue varied between 8.6% and 87.1%. This wide variability could be explained by heterogeneity in study design, sampling, analysis methodology, population, geographic location, or diet; these variations are summarized in Table 1 [38, 4648, 52, 63, 64] . For instance, higher F. nucleatum detection is seen when using CRC tissue samples and wholegenome shotgun metagenomics sequencing methods, as compared with fecal samples or bacterial 16s sequencing [10, 26, 50] . Furthermore, caution should be taken when interpreting studies of FFPE samples, because FFPE samples provide a less accurate assessment of the microbiome when compared with freshfrozen samples [65] . Finally, patients typically undergo bowel preparation when tissue samples are collected, which may affect Fusobacterium detection or abundance in tissue samples [66] . We conclude that consistent associations are seen between Fusobacterium, mainly F. nucleatum, and CRCs, with variable prevalence of F. nucleatum in CRC subjects, which is likely due to heterogeneous methodologies. It would be of value Ahn et al [25] 2013 Vogtmann et al [26] 2016 Gao et al [27] 2015 [28] 2016 [29] 2015 Burns et al [30] 2015 [32] 2016 Marchesi et al [34] 2011 [36] 2012 [37] 2017 Allali et al [38] 2015 [40] 2014 [41] 2012 Chen et al [42] 2017 [44] 2015 [45] 2013 [47] 2016 [50] 2014 [51] 2013 [54] 2017 [55] 2015 Chen et al [57] 2012 [58] 2016 Japanese cohort: 9
CRCs ( [72] 2016 United Limitations to the Mehta et al [64] study include the use of FFPE as opposed to fresh colonic samples and the study's observational design.
One explanation for the relationship between diet and colonic F. nucleatum is the potential impact of diet on oral Fusobacterium abundance. However, in a populationbased casecontrol study, no associations were found between fiber intake and presence of oral Fusobacteria, and only modest positive correlations were found between consumption of saturated fatty acids, vitamin C, B vitamins, and vitamin E, on the one hand, and oral Fusobacteria abundance, on the other (P < 0.01) [67] . Furthermore, no associations were observed between oral Fusobacterium presence or abundance and CRC [68] . However, that could be due to the study design, whereby patients' oral microbiomes were sampled after CRC resection and treatment; the study also lacks oral hygiene data [68] . In summary, diet may have a differential impact on colonic F. nucleatum enrichment, with increased abundance of F. nucleatum in the colons of patients consuming a Western diet. Longterm consumption of a high fiber diet may reduce the risk of a subset of Yoon et al [78] 2017 Table 1 [3133, 39, 43, 4648, 69, 70] . This could be due to varying definitions of high versus low F. nucleatum enrichment, unmeasured dietary confounders, and comparisons of colon versus rectum cancers, as opposed to proximal versus distal location. However, a few research teams have observed differences by CRC location. Yu et al [71] identified an increased F. nucleatum prevalence and relative concentrations in CRCs proximal to the splenic flexure as opposed to more distal CRCs [42] . A recent report by Mima et al [72, 73] looked primarily at F. nucleatum enrichment in relation to CRC location and found significant relationships between F. nucleatumhigh CRC and location. The study used FFPE samples from a large United States CRC cohort and found a gradual linear increment in CRCs that had high number of F. nucleatum rDNA copies from rectum to cecum (2.5% vs 11%, respectively; P < 0.0001) [72, 73] . Contradictory findings were reported in two studies involving Chinese and Spanish cohorts with an increased detection and relative concentrations of Fusobacterium in CRCs distal to splenic flexure. These results could be due to small sample sizes, sampling bias, different geographic location and associated dietary patterns, or looking at Fusobacterium as opposed to F. nucleatum specifically [27, 37, 38] . The increased prevalence of F. nucleatum in proximal CRC coincides with the presence of invasive bacterial biofilms in 89% of right-sided colonic cancers and their surrounding normal mucosa, which may suggest a more active bacterial role in right CRC carcinogenesis [33] . Thus, current evidence is conflicting, but F. nucleatum may be more prevalent in CRC proximal to the splenic flexure, with a gradual increase in F. nucleatumhigh CRCs from rectum to cecum. The increased F. nucleatum in proximal CRCs maybe due to F. nucleatum favoring anaerobic conditions, the presence of bacterial biofilms that facilitate its presence or to the differential impact of colonic lumen content on F. nucleatum abundance [63, 64] . These associations are summarized in Figure 2A . (Table  1) [31, 46, 47, 61, 73] . F. nucleatum has also been associated with higher expression of BRAF and decreased MLH1 expression, both of which are seen in MSIhigh sporadic CRCs [46, 61, 69, 70, 73] . KRAS mutations are usually associated with lower CRC methylation (CIMP negative), and conflicting results were seen when the relation of F. nucleatum to KRAS mutation was evaluated [37, 46, 50, 69, 70, 74] . However, a large study by Ito et al [46] found no association between KRAS mutations and detection or number of F. nucleatum rDNA copies in CRC, which is consistent with an F. nucleatum predilection to CIMPhigh CRCs. A recent, more indepth investigation showed that presence of high number of F. nucleatum rDNA copies in CRC was associated with a 5fold increased risk of having MSIhigh CRCs, irrespective of CIMPhigh status or BRAF mutation status [73] . This suggests that CRCs with MSI high status are linked to F. nucleatum, whether owing to inherited, somatic, or epigenetic inactivation of MLH1 [5, 6] . Further testing that was restricted to MSIhigh CRCs showed that high relative concentrations of F. nucleatum rDNA was associated with CDKN2A (P16) promoter hypermethylation, a tumor suppressor gene associated with CIMPhigh CRC [69] .Thus, there is increasing evidence linking MSIhigh CRC to Fusobacterium, but ambiguity exists regarding whether the increased detection of Fusobacterium is a cause or consequence of MSIhigh status and associated molecular findings in colorectal neoplasia.
Fusobacterium associations with CRC stage and prognosis: Previous investigation has assessed
Fusobacterium in relation to CRC staging and patient survival with variable results, as summarized in Table  2 . High percentage of Fusobacterium rDNA copies in CRC tissue was associated with worse depth of invasion in two large studies that looked specifically at CRC prognosis [70, 73] . Heterogeneity was seen when F. nucleatum abundance was evaluated in relation to lymph node metastasis [32, 41, 42, 70, 71, 73] . None of the aforementioned studies found any associations between F. nucleatum and distal metastatic disease. Lastly, higher Fusobacterium rDNA was associated with more advanced CRC stage in 2 out of 11 studies, suggesting a lack of correlation between Fusobacterium abundance and the Duke's or tumor, node, metastasis (TNM) staging classifications [31, 32, 41, 46, 50, 72, 73] . Conflicting observations were made when F. nucleatum was investigated as a predictor of CRCspecific survival. However, in two large studies by Wei et al [70] and Mima et al [73] with 10year follow up, high quantity of F. nucleatum rDNA copies in CRC samples was associated with shorter CRCspecific survival after adjustment for multiple confounders. CRCspecific survival was assessed only secondarily in the other studies, with negative results [47, 48, 70, 73] . Heterogeneous observations were made when Fusobacterium enrichment was assessed in relation to overall survival in CRC patients [41, 46, 50, 70, 73] . A comprehensive evaluation by Mima et al [73] adjusted for many confounders and found no association between high, low, or negative F. nucleatum rDNA copies presence in CRC tissue and CRC patients' overall survival. The other two studies showing worsened overall survival had a shorter followup period and adjusted for fewer [48] United States cohort: 598 CRCs.
----No relation between F. nucleatum rDNA copies in CRC and CRC-specific survival or CRC overall survival-unknown follow up period Flanagan et al [50] Czech, German and [50, 70] . In one study, Fusobacterium subspecies were predominantly present in the gobletlike transcriptional CRC subtype [7476] . This CRC subtype confers good prognosis in chemotherapyuntreated patients, but it has a detrimental effect on prognosis when adjuvant chemotherapy or chemoradiation are used [77] . Thus, CRC treatments, as well as CRC molecular subtypes, need to be investigated when looking at the impact of F. nucleatum presence on CRC survival. The above evidence is conflicting but suggests a more aggressive CRC biology with shorter CRC disease-specific survival periods in the presence of F. nucleatum; however, there are no relations between F. nucleatum and CRC staging. Thus, clarification is warranted of whether F. nucleatum modulation in CRC tissue is associated with better disease-free and CRC-specific survival rates after accounting for CRC molecular features and treatments.
Temporality and biological gradient
F. nucleatum prevalence and enrichment was evaluated in CRC precursors in order to assess temporality and an earlier role in CRC carcinogenesis ( Figure 2B and Table 1 ). The number of rDNA copies of F. nucleatum was higher in normal rectal/left colonic biopsies of patients with tubular adenomas (TAs) compared with controls [43, 55] . The exception is a study that found no evidence of F. nucleatum in rectal biopsies of controls, TA patients, or CRC patients; this result is likely due to a small sample size [78] . Higher presence Park et al [69] South and relative percentage of Fusobacterium [29] and F. nucleatum [55, 79] rDNA copies was seen in stools of patients with TAs compared with those of controls. On the contrary, two studies found no significant difference in relative percentage of Fusobacterium [39] and F. nucleatum [54] rDNA copies in fecal samples of patients with TAs, advanced TAs, and controls. Reasons for this discrepancy could include the use of fecal samples, which may represent transit from oral microbiome and may not necessarily correlate with true Fusobacterium abundance in colonic tissue, as well as absence of information on prior antibiotic use [10, 26, 50] . Detection and relative percentage of Fusobacterium [28] and specifically F. nucleatum [46, 50, 55] rDNA copies were found to increase in colonic tissue as it progressed through the CIN pathway (healthy control vs TA vs tubulovillous adenoma [TVA] vs high grade dysplasia vs CRC). Interestingly, no difference in relative percentage of F. nucleatum DNA copies was observed between TA and TVA tissue when compared with surrounding normal tissues [28, 46, 50] . This finding maybe be due to presence of bacterial biofilms or precancerous molecular changes in the surrounding normal mucosa, despite normal histological appearance, which may favor the attachment or invasion of Fusobacterium [33, 80] . Data are limited but suggest no relation between adenoma size or burden and F. nucleatum rDNA copy numbers in rectal tissue [43] . Finally, F. nucleatum was associated with CIMPhigh and rightsided sessile serrated adenomas/ polyps (SSA/Ps) when SSA/Ps were compared with TAs [28, 46, 71] . Limitations to the above studies include an absence of information on concomitant preneoplastic tissue in patients who had hyperplastic polyps and the simultaneous use of FFPE and colonic preparation in specimens collected, which could reduce F. nucleatum detection [66, 81] . All these data suggest that there may be a stepwise increase in F. nucleatum rDNA quantity and detection as colorectal neoplasms progress through the CIN pathway. Furthermore, F. nucleatum may play an earlier role in the CIMPhigh CRC pathway. These results suggest temporality and a biological gradient of F. nucleatum in CRC development.
Plausible mechanisms and experimental evidence
Despite the accumulating associations between Fusobacterium/F. nucleatum and colorectal neoplasia, establishing direct causality is challenging with the absence of prospective human studies supported by correlative laboratory science. In brief, multiple observational and animal experimental studies suggest plausible mechanisms by which F. nucleatum may contribute to CRC development, and these warrant additional investigation ( Figure 2C ).
F. nucleatum transmission to colorectal neoplastic tissue:
Rats treated with 1,2-dimethylhydrazine (DMH) had increased Fusobacterium detection in tumors, whereas it was absent in nontreated controls, indicating a predilection of Fusobacterium to tumor tissue [82] .
Oral administration of F. nucleatum into APC min/+ and DMH-treated mice led to colorectal colonization and promoted colorectal neoplasia development, suggesting an active role of F. nucleatum in CRC neoplasia [55, 79] . Similar findings were not seen in wildtype mice, suggesting that F. nucleatum can be contracted through oral ingestion if individuals are already predisposed to CRC. The mechanism by which F. nucleatum reaches the colonic epithelium are unclear. However, some F. nucleatum strains display the potential to disrupt the colonic mucosal barrier, suggesting that it can be transmitted from the colonic lumen to the epithelium, potentially causing colorectal disease [60] .
Other Fusobacteria may take advantage of coinfection with other invasive bacteria or of disruption of the mucosal layer, seen with CRC. Another mechanism by which Fusobacteria home and localize to dysplastic colorectal epithelium is the bloodborne route [83] . In a novel study, a host lectin (GalGalNAc) was shown to mediate F. nucleatum attachment to CRC and precursor cells through interaction with an F. nucleatum protein, fibroblast activation protein 2 (FAP2) [83] . The expression of GalGalNAc is increased in a stepwise fashion in colorectal adenoma and matched surrounding normal tissue to villous adenomas with highest levels seen in CRC [83, 84] . In a prior study, GalGalNAc was also more abundant in visually normal colonic epithelium of patients with CRC and its precursors, when compared to healthy controls [85] . GalGalNAc is mainly expressed in embryonic colonic goblet cells, and, in parallel, Fusobacterium was predominantly present in the gobletlike transcriptional CRC subtype [76, 8587] . The above data suggest that F. nucleatum can be localized through the lumen, or it can be blood borne. F. nucleatum's preferential adherence to colorectal neoplasia maybe due to increased colonic epithelial GalGalNAc expression potentially due to gobletlike transformation of colorectal dysplastic epithelium. This increased GalGalNAc expression may explain F. nucleatum's prevalence in visually normal colonic tissue of predisposed individuals, as well as F. nucleatum's stepwise abundance through the adenomacarcinoma sequence. Further evaluations confirming the goblet like transformation of visually normal appearing colonic tissue of CRC patients in relation to Fusobacterium and bacterial biofilm formation are warranted.
F. nucleatum leads to increased expression of oncogenic and inflammatory factors early in CRC development: Stool metabolomics and CRC tissue inflammosome analysis supported associations between Fusobacterium [31, 88] , specifically F. nucleatum [45, 89] , and inflammatory metabolites as well as pathways implicated in colon carcinogenesis: Interleukin (IL) 6, IL8, IL10, IL17F, IL21, IL22, the Regenerating gene family, tumor necrosis factor (TNF), Matrix metallopeptidase 9 (MMP9) and Nuclear Factor kappa B (NF-κB) [70, 76, 9092] . Quantity of F. nucleatum rDNA copies and inflammatory markers were both higher in visually normal rectal mucosa of adenoma patients compared with healthy controls [43, 89] . Fluorescence in situ Hybridization (FISH) further confirmed the presence of F. nucleatum in the mucus layer and within colonic crypts of normal appearing colonic mucosa [43] . Bacterial biofilms were also found to cover normal appearing colorectal mucosa adjacent to CRC; and this was associated with an increase in colonic epithelial proliferation, IL6 and STAT3 activity as well as decreased Ecadherin in the normal appearing colonic epithelium [33] . All this suggests that F. nucleatum is associated with increased colorectal inflammation in CRC tissue. There is also an association between of presence of F. nucleatum rDNA and inflammation in visually normal appearing colorectal epithelium. The presence of inflammation in normal appearing colonic epithelium could potentially be due to presence of bacterial biofilms. These findings are interesting since inflammation is considered to be a marker of carcinogenesis which suggest a potential early role for F. nucleatum in carcinogenesis even prior to adenoma formation [93] . Indeed, data showed that incubation of F. nucleatum with CRC cell lines promotes proliferation and invasion of CRC cell in vitro and mice xenograft modules [91] . Experimental mouse data using APC Min/+ and DMH models are supportive showing that F. nucleatum ad ministration increases the number and size of aberrant crypt foci and colorectal tumors, with activation of JAK/STAT and MAPK/ERK pathways critical for CRC development [55, 79, 91] . The mechanism for MAPK activation is thought to be due to recognition of F. nucleatum li popolysaccharide by tolllike receptor 4 (TLR4) surface protein present on CRC cells leading to initiation of the TLR4/MYD88/NF-κB pathway, with subsequent binding of NF-κB to the micro RNA (miRNA)-21 promoter site [42, 91] . This leads to increased expression of miRNA 21 which regulate RASA1 gene with subsequent activation of the MAPK pathway [91] . Similarly, F. nucleatum lipopolysaccharide possibly activates the TLR4/p21 activated kinase 1 (PAK1) cascade with subsequent increased β-catenin expression [42] . In parallel, it is proposed that F. nucleatum's adhesion molecule, FadA, mediates induction of E-cadherin/β-catenin with subsequent abundance of target genes, such as C-myc and CCND1 [89, 91] . These proposed mechanisms are described in Figure 2C . In a recent study, F. nucleatum 2 equipped with FadA and FAP2 proteins did not increase inflammation or promote CRC in APC Min/+ nor in IL10 knockout mice, suggesting that FadA and FAP2 are necessary but not sufficient to promote CRC [94] . This could be due to some F. nucleatum strains having distinct virulence factors and/ or distinct lipopolysaccharides that are associated with more invasive and inflammatory behavior [60] . Functional pathway analysis supports this hypothesis, with increased bacterial virulence and motility protein pathways in F. nucleatuminvading CRC tumors [30] . Finally, F. nucleatum invasion and survival inside colorectal cells may cause increased production of reactive oxygen species [92, 95] . The resultant activation of inflammatory cascades is hypothesized to induce DNA damage and epigenetic silencing of key targets, such as the mismatch repair gene MLH1, potentially leading to MSI seen frequently with F. nucleatum [46, 61, 89, 9092] . Additional investigation is warranted focusing upon the relationship between virulent Fusobacterium strains, specifically F. nucleatum, and induction of an inflammatory microenvironment that facilitates epigenetic and genetic alterations involved in early colorectal carcinogenesis.
F. nucleatum modulates the tumor immune microenvironment favorably towards carcino genesis: Mounting evidence suggests that F. nucleatum modulates the microenvironment at the interface between the developing cancer and the host immune response. For instance, F. nucleatum rDNA abundance in tumor tissue was correlated with host immune response genes and oncogenes [45] . F. nucleatum can impact tumor Tcell abundance by inducing Tcell apoptosis, as well as by reducing Tcell proliferation, activation and response to certain mitogens and antigens [79, 96102] . This effect could be due to the FAP2 protein of F. nucleatum directly interacting with Tcell immunoreceptor with immunoglobulin (Ig) and ITIM domains (TIGIT), leading to the inhibition of natural killer (NK) cellinduced tumor cytotoxicity. Other tumor-infiltrating CD3+ T cells (CD4+ and CD8+) also have TIGIT and are possibly inhibited by FAP2 [103] . This is consistent with the observation that Fusobacteriumhigh CRC cases are inversely associated with the density of CD3+ T cells, a type of T cell that is usually associated with better patient survival [48] . In parallel, Forkhead box P3 (FOXP3)low T cells do not possess tumor suppressive activity and can secrete proinflammatory cytokines. FOXP3low Tcellinfiltrated CRCs show increased expression of inflammation and immunemediated genes such as IL12A, IL12B, transforming growth factor (TGF)beta 1, and TNF, and they are associated with F. nucleatum abundance, paradoxically conferring better CRCfree survival [104] . F. nucleatum also recruits CD11b myeloid-derived immune cells, which are precursors to macrophages, consistent with the finding of increased tumor macrophages in the presence of F. nucleatum [69, 79, 105] . Furthermore, F. nucleatum induces activation of the CCL20/CCR6 axis in monocytes and CRC cells, potentially promoting monocyte migration and CRC development [56] . Thus, F. nucleatum abundance is associated with increased CD68 tumor-infiltrating macrophages, monocytes, and FOXP3-low T cells, but lower infiltration of CD3 lymphocytes. These findings support the hypothesis that F. nucleatum may exert an immunosuppressive effect in the cancer microenvironment that promotes the sustained survival of CRC cells. It may also explain the mystery of why the high load of MSIinduced antigens does not lead to immune eradication of MSIhigh CRCs; this could be due to infiltration by F. nucleatum and associated immunosuppression. The relation between the immune microenvironment and prognosis is still controversial, and future studies linking bacteria such as Fusobacterium to survival through peripheral immune modulation are warranted.
Practical applications of fn in CRC prevention
The accumulating literature linking F. nucleatum to CRC led to efforts investigating the utility of F. nucleatum in CRC detection. Fecalbased F. nucleatum polymerase chain reaction (PCR) can serve as a noninvasive tool for CRC detection, with even better results when using digital PCR based on wateroil emulsion droplet technology [39, 54, 106109] . Compared with PCR, loop-mediated isothermal amplification (LAMP) is a simple, noncostly and accurate method for bacterial testing that was shown to be more sensitive than PCR for F. nucleatum detection [110] . Two drawbacks of LAMP are the potential for false positivity and the complex design primer used. Metagenomic analysis of fecal microbiome across European and Chinese cohorts also showed that butyrylCoA dehydrogenasegene F. nucleatum gene markers accurately distinguished CRC cases from controls, with area under the curve (AUC) = 0.84 and an odds ratio of 23 [111] . Finally, Wang
et al [112] demonstrated that F. nucleatum can also induce a serological antiF. nucleatumIgA immune response that is higher in CRC patients compared with patients with benign colonic polyps, those with inflammatory bowel disease, and healthy controls.
In that study, the combination of antiF. nucleatum IgA and carcinoembryonic antigen (CEA) was found to better for diagnosing CRC compared with either one alone (sensitivity: 53.10%; specificity: 96.41%; AUC = 0.848). The finding that diet can alter the microbiome and associated colonic carcinogenesis led to efforts investigating F. nucleatum modulation in CRC chemoprevention and therapeutics through the use of probiotics and herbals [63] . Probiotics including
Bifidobacterium longum, Lactobacillus acidophilus and Enterococcus faecalis significantly reduced
Fusobacterium levels by nearly 5fold in CRC surgery patients when compared with placebo probiotics (10.08% vs 1.91%, respectively; P = 0.03) [113] .
Limitations of that study include the variable length of probiotic treatment and the presurgery use of antibiotics and bowel preparation, which can alter the microbiome [113] . Berberine (BBR) is an isoquinoline alkaloid and a component of the Chinese herb Coptis chinensis. BBR was shown to prevent insulin resistance and obesity in mice fed a highfat diet, in association with an impact on the intestinal microbiome [114] . Administration of BBR to APC Min/+ and DMH mice inoculated with F. nucleatum led to reduced tumorigenesis and Fusobacteriuminduced activation of the JAK/STAT and MAPK/ERK pathways [55] . Both probiotics and herbals may provide tactics for modulating F. nucleatum, but the implications are still under investigation.
Conclusions
Fusobacteria are significantly more abundant in colorectal tissues and stools of patients with CRC than in healthy controls. The histopathology of these findings is ambiguous, but the few available data suggest that Fusobacteria have been observed within the colonic biofilms, the colonic mucus layer, colonic crypts, and inside the colonic epithelium. F. nucleatum has been associated with proximal CRCs and CRCs with MSI-high features, a finding warranting additional investigation. Findings also suggest temporality and a biological gradient with presence of fusobacteria in CRC precursors. Further, researchers have observed increased detection and quantity of F. nucleatum rDNA in the visually normal mucosa of colorectal neoplasia patients when compared with healthy controls. The pathophysiology and significance of this finding is unclear, as is its relation to cancer progression. Fusobacteria are usually indigenous to healthy mouth microbiota, highly adherent to teeth and oropharyngeal epithelium in the presence of a low viscous saliva environment, and unspecialized for viscous environment. Therefore, they are normally only transient in the colon, which is protected by a mucus layer. Disruption of the colonic mucus layer or coinfection with other invasive bacteria may facilitate the presence of Fusobacterial species in CRC tissue. Furthermore, some Fusobacterial strains, specifically F. nucleatum, are considered active invaders, giving them the potential to disrupt an intact colonic mucosal barrier and potentiate colorectal disease. The presence of a host lectin (GalGalNAc) in the colon may also mediate F. nucleatum bloodborne transmission and attachment to CRC and precursors through interaction with an F. nucleatum protein, FAP2. F. nucleatum was demonstrated to have cancerpromoting properties in several rodent models, supporting its role in the human colon cancer cascade. This is thought to be due to its activation of inflammatory and oncogenic pathways associated with colon carcinogenesis, as well as its modulation of the immune microenvironment in a manner that favors cancer progression. The lack of prospective human studies is a large limitation of current literature regarding the temporality of Fusobacterium and cancer; most human studies to date were crosssectional casecontrol studies. Thus, more evidence is needed to confirm causality and inform future detection and therapeutic efforts targeting F. nucleatum and other microbiota involved in CRC.
ARTICLE HIGHLIGHTS
Research background
The presence of Fusobacterium, specifically Fusobacterium nucleatum (F. nucleatum), in the colon is increasingly linked to colorectal cancer (CRC). However, significant heterogeneity in study methods and findings poses challenges to interpretation. An evaluation of this rapidly expanding literature will help direct future studies to answer unresolved questions and to avoid previous design pitfalls in order to further our knowledge in this exciting field.
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ARTICLE HIGHLIGHTS
Research motivation
A critical evaluation of the scientific literature regarding the link between Fusobacterium/F. nucleatum and CRC may contribute to the development of more comprehensive and novel studies to better define this relationship and its potential applications in CRC treatment and prevention.
Research objectives
This systematic review evaluated the clinical and experimental evidence linking Fusobacterium and CRC. The authors reviewed studies investigating the relationship between Fusobacterium and the following variables: CRC, CRC patients' characteristics and dietary patterns, CRC anatomic location, CRC molecular features, and CRC stage and prognosis. The authors also reviewed studies looking at presence of Fusobacterium in pre-neoplastic lesions, as well as experimental evidence testing the procarcinogenic potential of Fusobacterium. Finally, the authors looked at the implications of Fusobacterium for CRC detection and treatment. Elucidating these heterogeneous studies may impact our understanding of the relationship between Fusobacterium and CRC, as well as improve detection and chemoprevention tactics for CRC.
Research methods
This is, to our knowledge, the first systematic review of the scientific evidence surrounding the link between Fusobacterium and CRC. Using PubMed, Embase, and Medline, the authors systematically reviewed all original studies investigating Fusobacterium/F. nucleatum and CRC published between January 1st, 2000, and July 1st, 2017. All abstracts were screened to identify original human, animal, and in vitro research. Out of the 355 articles that were screened, 90 articles were included in this review. Articles were excluded if diseases other than CRC were included and if they were written in languages other than English. All review articles and citations including only an abstract were excluded from analysis.
Research results
An accumulating body of evidence supports the hypothesis that Fusobacterium, especially F. nucleatum is more frequently detected in colorectal neoplasia, especially the microsatellite instability neoplastic pathway and proximal CRC. Studies investigating F. nucleatum in colorectal precancerous tissue suggest temporality and a biological gradient; however, ambiguity still exists on whether this increased detection of Fusobacterium is a cause or consequence of colorectal neoplasia. Diet may have a differential impact on colonic F. nucleatum enrichment, high fiber diet potentially reducing the risk of a subset of CRCs that are F. nucleatum-positive. Evidence also suggests a shorter CRC disease-specific survival in the presence of F. nucleatum, albeit with no relations between F. nucleatum and CRC staging. The homing of Fusobacteria and F. nucleatum to the colonic epithelium maybe partly due to increased Gal-GalNAc expression on colonic cells, virulence factors of F. nucleatum and other Fusobacteria, and changes to the local colonic environment with disruption of the protective mucus layer. Experimental evidence suggests that Fusobacterium nucleatum has a procarcinogenic potential that is likely mediated by activation of oncogenic and inflammatory pathways, as well as modulation of the tumor immune environment. The lack of prospective human studies is a large limitation of current literature. Furthermore, it will be essential to further delineate mechanisms and timing of Fusobacterium homing to the colonic mucosa, as well as its relation to cancer progression. This review may be used to develop hypotheses for novel strategies targeting colorectal cancer detection and prevention. Future robust analysis would also benefit from adjusting for confounders, such as Fusobacterial strain virulence factors, colonic preparation, antibiotic use, and diet.
Research conclusions
Accumulating evidence supports the hypothesis that F. nucleatum may enhance colorectal carcinogenesis, especially the neoplastic pathway involving defects in microsatellite instability. Virulence factors of F. nucleatum may contribute to its procarcinogenic effect. The lack of prospective human studies is a large limitation of current literature regarding the link between Fusobacterium and CRC. This review may be used to guide novel strategies targeting colorectal cancer detection and prevention.
Research perspectives
This review gathers an ample evidence implicating Fusobacterium in CRC etiology and highlights the promising global efforts aimed at testing the role of Fusobacterium in CRC detection, chemoprevention and outcomes. There are multiple gaps in knowledge and the current evidence lacks prospective human studies. To advance our knowledge, future prospective studies need to clarify the timing and mechanisms of Fusobacterium transmission to the colon in relation to colorectal carcinogenesis and histopathology of these findings. In order to potentially design future CRC therapies, additional investigations are also warranted to delineate the relationships between virulent Fusobacterium strains, specifically F. nucleatum, and induction of inflammatory, pro carcinogenic and immune mechanisms involved in early colorectal carcinogenesis. Furthermore, future efforts need to prospectively test the impact of diet, probiotics and other chemopreventative agents on colonic Fusobacterium and whether modulation of colonic presence/concentrations of Fusobacterium will alter the risk or outcomes of CRC. Finally the role of Fusobacterium in CRC screening is intriguing and studies combing Fusobacterium testing with other CRC screening methods such as stool DNA testing or even colonoscopy may potentially improve CRC detection and preventative efforts. This study outlines the significant heterogeneity in the methods used and the need for more consistent design. In order to attain more robust results, the authors suggest future studies to: (1) use a blinded prospective randomized controlled design and/or large sample size when possible; (2) perform better sampling by collecting unprepared colonic tissue stored as fresh frozen samples; (3) have more detailed microbiome sequencing using whole-genome shotgun metagenomic sequencing, FISH and other methods in order to assess Fusobacterium sub-species concentrations, the presence of virulence factors and location of Fusobacterium in relation to the colonic epithelium; and (4) adjust for potential dietary, geographic and racial variables that may have an impact on Fusobacterium/F. nucleatum presence or concentration within specimens.
